Expression of GFP-BLM (aa 181–212) augmented the rate of tumorigenesis (Figure 3J), indicating that the 32–amino acid stretch in BLM that interacted with RAD54 promoted tumor growth, even in the presence of the chemotherapeutic drug CPT. Here, BLM is linked to neoplasm.